ENTITY
Nektar Therapeutics

Nektar Therapeutics (NKTR US)

17
Analysis
Health CareUnited States
Nektar Therapeutics is a clinical-stage biopharmaceutical company which develops a pipeline of drug candidates that utilize company platforms. The Company's product pipeline is comprised of early to late stage drug candidates across a number of therapeutic areas including oncology, pain, anti-infectives, anti-viral and immunology.
more
Company Event07 Mar 2026 05:00 • Upcoming
Add To Calendar
Company Event16 Dec 2025 21:00 • Latest
Company Event20 Nov 2025 19:00
Company Event07 Nov 2025 06:00
Company Event08 Aug 2025 05:00
x